Angiogenesis in hepatocellular nodules: Correlation of MR imaging and vascular endothelial growth factor
✍ Scribed by Masayuki Kanematsu; Richard C. Semelka; Polytimi Leonardou; Maria Mastropasqua; Diane Armao; Georgeta Vaidean; Zeynep Firat; John T. Woosley
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 851 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To assess the correlation between magnetic resonance (MR) imaging findings and angiogenetic activity in hepatocellular nodules evaluated by immunohistochemical staining with antibody of vascular endothelial growth factor (VEGF).
Materials and Methods
We searched the pathologic records of our institution from December 1999 to April 2002, and included 16 patients with hepatocellular carcinoma (N = 14), large regenerative nodule (N = 1), and dysplastic nodule (N = 1) who underwent orthotopic liver transplantation (10 patients) or partial hepatectomy (six patients) and MR imaging within an interval of two weeks. The MR images were retrospectively assessed qualitatively and quantitatively. Angiogenetic activity of the hepatic nodules was evaluated by means of immunohistochemical study for VEGF. Analysis of variance and the Scheffé criterion were used for statistical evaluation.
Results
Hepatic nodules with moderate to strong immunoreactivity for VEGF showed higher signal intensity on T1‐weighted images (P < 0.05) and those with intense immunoreactivity for VEGF showed higher signal intensity on T2‐weighted images (P < 0.05). No correlation was found between the immunoreactivity for VEGF and tumor vascularity on postcontrast early‐ and late‐phase images.
Conclusion
Our current results suggest that signal intensity on unenhanced T1‐ and T2‐weighted MR images may correlate with immunoreactivity for VEGF. Correlation was not found between immunoreactivity for VEGF and signal intensity on gadolinium‐enhanced MR images. J. Magn. Reson. Imaging 2004;20:426–434. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Vascular endothelial growth factor (VEGF) is thought to take an important role in tumor angiogenesis. The present study examined VEGF expression immunohistochemically in hepatocellular carcinomas (HCCs) in various histological grades and sizes. In HCCs that were composed of cancerous tissues of sing
Neovascularization appears to play an early and important part in the evolution of psoriatic plaques. We studied the distribution and production of two known angiogenesis factors, endothelial cell stimulating angiogenesis factor (ESAF) and vascular endothelial growth factor (VEGF), in the skin of pa
As in other tumors, the assessment of microvessel density (MVD) in hepatocellular carcinoma (HCC) may be essential to perform an effective anti-angiogenic therapy for this tumor. The relationship between vascular endothelial growth factor (VEGF) and MVD of HCC as well as the surrounding liver remain